Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...

Boss Energy's Duncan Craib thinks a uranium price breakout is still on the way, as responded to critics with a strong ...

Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

Lithium demand will continue to grow from technology stretching far beyond electric vehicles, says PLS boss Dale Henderson.

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial ...

NT gold stock Emmerson says White Devil resource is a key milestone, while Boss success leads uranium shares higher.

Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ...

Aussie tech start-ups have been warned by one of the tech sector's most successful investors to avoid raising too much too ...

Emissions can be cut, but 'pragmatist' Emirates President Sir Tim Clark is doubtful net zero aviation can be a reality.

Smart money is flowing for Omega Oil & Gas, with minted energy investor Tri-Star Group boosting its stake to 19.9% as part of ...